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Hydroxyapatite (HA) is a precursor of bone and has been studied as a biomaterial. We attempted HA to apply to protein delivery
systems.Inthisstudy,theassociationanddissociationpropertiesoftwotypesofbioactiveproteins,cytochromcandinsulin,toHA
were investigated. Cytochrom c was less associated with HA than insulin, which was easily released from it. However, the release
of insulin from HA was slow. Insulin was released from HA at pH 7.4 more rapidly than at pH 3. The association and dissociation
properties might be inﬂuenced by the size, solubility and net charge of protein. HA is a potential protein carrier with controlled
release.
1.Introduction
Drug delivery systems (DDSs) are useful for reducing drug
side eﬀects and maximizing drug action. The design of
drug carriers for DDS is the most important activity in this
area. The advent of molecular biology studies has enabled
the identiﬁcation of many disease-causing proteins. Because
some of these are eﬀective as drugs, protein delivery systems
have become important in DDS. A variety of nanoparticles
suchasliposomes,micelles,andpolymershavebeenadopted
as drug carriers [1–4]. Because polymers are similar in
size to proteins, they are not suitable as protein carriers.
Whereas liposomes and micelles are larger than polymers
and proteins, they can be used as protein carriers. However,
because these are self-assembled nanoparticles, some treat-
ments are necessary for their preparation as carriers. Since
most proteins are sensitive to temperature, pH, and organic
solvents, it is possible that such treatments induce protein
denaturation.
Hydroxyapatite (HA), Ca10(PO4)6(OH)2,i sam a j o r
component of hard tissues such as bones and teeth and
has been used as a biomaterial [5, 6]. Because it has been
reported that some proteins, such as bovine serum albumin
(BSA) and lysozyme, can bind to HA just by mixing, it is
a good candidate for a protein carrier [7–9]. In this study,
we investigated the association and dissociation behavior
of two bioactive proteins, cytochrome c and insulin, to
HA. It is known that the release of cytochrome c from
mitochondria to the cytosol induces apoptosis. Therefore,
the delivery of cytochrome c into the cytosol of cancer cells
should induce apoptosis, which may be useful for cancer
therapy [10]. Insulin, a key protein of diabetes, is commonly
injected into diabetic patients to suppress blood sugar levels
[11], and its controlled release can markedly improve their
quality of life. Because the delivery of these two proteins is
important, we attempted to use HA for a delivery system.
The absorption and desorption on HA were aﬀected by the
surface conditions dependent on the preparation procedure
of HA. Considering universal use of HA for protein delivery,
commerciallyavailable HA was used as a carrier in this study.
2.MaterialsandMethods
HA nanoparticles were purchased from Sigma-Aldrich (MO,
USA). According to the material data sheet (no. 677418),
the size and surface area were smaller than 200nm and2 Journal of Drug Delivery
Table 1: Proteins used in this study.
Protein Mw (Da) pI
Cytochrome c 12384 10.7
Insulin 5734 5.3
Mw: molecular weight, pI: isoelectric point.
larger than 9.4m2/g, respectively. Cytochrome c and insulin
were obtained from Nacalai Tesque Inc. (Kyoto, Japan).
Physicochemical properties of proteins used in this study
are listed in Table 1. Cytochrome c is cationic, and insulin
is anionic at physiological pH, and the molecular weight of
cytochrome c is larger than that of insulin.
Adsorption experiments with cytochrome c were per-
formedbymixingHA(0,10,20,and30mg)withanaqueous
solution (2.5mg/mL, 200μl). After 4h mixing with a rotator,
centrifugation (15,000g, 20◦C, 60min) was performed to
collect the supernatants. These were analyzed by reversed
phase high performance liquid chromatography (HPLC) to
estimate the residual concentration of cytochrome c. The
HPLCsystemwasequippedwithacosmosil5C18-MS-IIcol-
u m n( N a c a l a iT e s q u e ,I n c . ,K y o t o ,J a p a n )a n daU Vd e t e c t o r
(220nm; UV-2075Plus, Jasco Inc., Tokyo, Japan). Samples
(5μl) were injected with an autosampler (AS-2057Plus,
Jasco Inc., Tokyo, Japan) and eluted with acetonitrile/0.05%
triﬂuoroacetic acid = 20/80 (A) and acetonitrile/0.05%
triﬂuoroacetic acid = 60/40 (B) at 1.0mL·min−1 by PU-
2089Plus (Jasco Inc., Tokyo, Japan). A linear gradient elution
was performed over 20min from an initial state (A) 100% to
the ﬁnal state (B) 100%. In the case of insulin adsorption,
the same experimental procedures were performed except
the insulin solution was prepared by dissolving it in 0.01N
HCl and adjusting to pH 3. Association ratio (%) was
calculated as [(C0−C)/C0] ×100, at which C0 a n dCa r et h e
initial concentration and the supernatant concentration of
proteins, respectively.
During desorption experiments, HA (10 and 20mg)
absorbing cytochrome c and insulin was transferred into
400μl of phosphate buﬀer saline (PBS; 8mM Na2HPO4,
2mM KH 2PO4,1 3 7 m MN a C l ,3 m MK C l ) ,a n dr o t a t e d .
After predetermined incubation times, centrifugation
(15,000g, 20◦C, 60min) was performed to collect the
supernatants. The residual concentrations of cytochrome c
and insulin were estimated by HPLC. In the case of insulin,
PBS adjusted to pH 3 was also used as the incubation buﬀer.
Dissociation ratio (%) was calculated as [C/C0] ×100, at
which C0 and C are the total concentration of the associated
proteins and the supernatant concentration, respectively.
3. Results andDiscussion
The association experiments were performed by mixing
HA and protein solutions. Cytochrome c was soluble in
deionized water, but insulin was not. Therefore, insulin was
dissolved in an acidic solution (pH 3). After the incubation
and subsequent centrifugation, the residual cytochrome c
and insulin in the solution were estimated from the HPLC
analysis. Cytochrome c and insulin were eluted after 10min
and 13min, respectively, under the running conditions
(Figure 1(a)), and the peak areas were proportional to
the protein concentrations (Figure 1(b)). Thus, the protein
concentrations in the supernatants were evaluated by HPLC
analysis and the adsorbed amounts were calculated by
subtracting the concentrations in the supernatant from the
initial ones. Figure 2 shows the association ratio of these
proteins on HA. Both proteins were associated with HA after
the 4h incubation. The adsorption eﬃciency of insulin was
higher than that of cytochrome c. As less as 10mg HA was
suﬃcienttoloadalmost0.5mginsulin, but30mgHAisnec-
essary to load the same amount of cytochrome c under this
condition. This may be because cytochrome c is larger than
insulin. From the surface area of the HA (>9.4m2/g) and the
protein diameters (d) of insulin (3nm) and cytochrome c
(4nm) [12], the percent of occupied area can be estimated.
In the experiment, 0.5mg of proteins, that is 9 × 10−8mol
(5 × 1016 molecules) of insulin and 4 × 10−8mol (2 ×
1016 molecules) of cytochrome c, were used. The projected
area of proteins may be approximated as π(d/2)2, assuming
the protein to be spherical. Given that all molecules were
absorbed, the occupied areas of insulin and cytochrome c
were 0.4m2 and 0.3m2, respectively. The surface area of HA
(10mg, 20mg, and 30mg) can be calculated as >0.094m2,
>0.19m2,a n d>0.28m2, respectively. It is suggested that the
surface area of HA was fully occupied by proteins. Even
though the absorption amount of cytochrome c could be
correlated to the total surface area of HA, that of insulin
could not. It is possible that insulin was absorbed to form
multilayered structures.
Figure 3 indicates time-dependent association of
cytochrome c to HA. Long-term incubation contributed
to the eﬃcient loading of cytochrome c even with a small
amount of HA. Figure 3 also indicates that cytochrome
c bound to HA in two phases. The initial absorption
occurred in less than 1h, and the subsequent absorption
occurred more slowly, in the range of an hour. The ﬁrst
absorption phase might be attributed to surface absorption
and the latter by penetration into the pores. The release of
cytochrome c was also examined at diﬀerent incubation
times. The release proﬁles also occurred over two phases,
in less than 1h and over the hour range (Figure 3), similar
to the adsorption proﬁle. This result suggests that absorbed
proteins at the surface were released very fast and those
within the pores were released more slowly. Thus, regulation
of release can be achieved by the control of protein size and
the pore size of HA. It is possible that step-by-step protein
release can be performed in an HA-based delivery system.
Figure 2 shows that insulin was readily bound to HA.
We also investigated the release proﬁles of insulin (Figure 4).
Less than 40% of the bound insulin was released from HA,
even though 70% of cytochrome c was released after 24h.
Insulin is smaller than cytochrome c and readily bound
to HA (Table 1 and Figure 2), but the release of insulin is
slower than that of cytochrome c (Figure 4). Therefore, this
phenomenon was not related to protein size or absorption
mechanism. It is likely that the slow release may be caused
by its poor solubility in PBS, compared to cytochrome c. The
release of insulin was next examined at pH 3, because insulinJournal of Drug Delivery 3
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Figure 1: HPLC analysis. (a) Chromatograms of cytochrome c (top) and insulin (bottom). (b) Correlations between the peak area and the
concentrations of cytochrome c (solid symbols) and insulin (open symbols).
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Figure 2: Association of cytochrome c (solid symbols) and insulin
(open symbols) with various amounts of HA after 4h.
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Figure 3: Time-dependent association (solid symbols) and dissoci-
ation (open symbols) of cytochrome c with HA (20mg).
is easily soluble in acidic solution, which is a condition of
the association. However, the release at pH 3 was slower
than that at pH 7.4 and was perhaps aﬀected by the charge
of insulin. Insulin has an isoelectric point (pI) of 5.3 so
is positively charged at pH 3 and negatively at pH 7.4.
Hydroxyapatite is mostly negative, so cationic insulin might
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Figure 4:Time-dependentdissociationofinsulinfromHA(10mg)
at pH 7.4 (solid symbols) and pH 3.0 (open symbols).
be more interactive with HA. A decrease in insulin release
was observed, especially at pH 7.4 after more than 5h.
The readsorption of the released insulin to HA might have
occurred, because the desorption conditions diﬀered from
the absorption condition.
Our results suggest that the association and dissociation
properties to HA were aﬀected by both the charge and size
of proteins. HA has a hexagonal structure, in which the C
(Ca-rich) site is arranged in the a–c and b–c planes and the
P (Ca-deﬁcient) site is in the a–b plane. It was reported that
anionic molecules bind to the C site and cationic ones to the
Ps i t e[ 8]. Therefore, HA-based protein delivery is suitable
for pH-dependent controlled release. Cationic cytochrome c
and anionic insulin at the physiological pH were absorbed
a n dd e s o r b e di nd i ﬀerent manners. Because the charge
of insulin was changed with decreasing pH, it markedly
inﬂuenced the adsorption and desorption behaviors. The
absorption behavior may be very complex, because large
protein molecules bind to HA at multiple points. Therefore,
the regulation of controlled release of protein is still to be4 Journal of Drug Delivery
investigated (For further information, see Supplementary
Material available online at doi:10.1155/2012/932461.).
4. Conclusions
In conclusion, we prepared protein-associated HA and
characterized its association and dissociation properties.
Cytochrome c and insulin could bind to and release from
HA. However, their association and dissociation behaviors
diﬀered, depending on the size and charge of the proteins.
Therefore, HA is a potential carrier for protein delivery
systems.
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